Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors

Cody J. Peer, Daniel A. Goldstein, Jennifer C. Goodell, Ryan Nguyen, William D. Figg*, Mark J. Ratain

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences